Demographic characteristics |
Women, n (%) |
69 (53.5%) |
Age at mid‐life measurement, median [Q1, Q3] |
55.1 [54.2, 55.8] |
Age at death, median [Q1, Q3] |
84.1 [77.2, 87.2] |
Education |
No high school degree, n (%) |
14 (10.9%) |
High school degree, n (%) |
35 (27.1%) |
Some college, n (%) |
34 (26.4%) |
College graduate, n (%) |
46 (35.7%) |
Clinical characteristics |
Mid‐life FSRP, mean ± SD |
1.3 ± 0.8 |
Late‐life FSRP, mean ± SD |
20.3 ± 14.1 |
Time (years) from mid‐life FSRP to death, median [Q1, Q3] |
33.4 [26.3, 37.2] |
Time (years) from final FSRP to death, median [Q1, Q3] |
4.4 [3.0, 6.8] |
ApoE ɛ4 carriers, n (%) |
32 (24.8%) |
Clinical dementia rating |
None (0.0), n (%) |
48 (37.8%) |
Very mild (0.5), n (%) |
22 (17.3%) |
Mild (1.0), n (%) |
12 (9.5%) |
Moderate (2.0), n (%) |
16 (12.6%) |
Severe (3.0), n (%) |
29 (22.8%) |
FSRP components at mid‐life |
Systolic blood pressure, mean ± SD |
124 ± 14 |
Current smoking, n (%) |
32 (24.8%) |
Antihypertensive medication, n (%) |
10 (7.8%) |
Prevalent diabetes mellitus, n (%) |
2 (1.6%) |
Prevalent cardiovascular disease, n (%) |
3 (2.3%) |
Prevalent atrial fibrillation, n (%) |
3 (2.3%) |
FSRP components at final measurement |
Systolic blood pressure, mean ± SD |
136 ± 20 |
Current smoking, n (%) |
6 (4.7%) |
Antihypertensive medication, n (%) |
69 (53.5%) |
Prevalent diabetes mellitus, n (%) |
13 (10.1%) |
Prevalent cardiovascular disease, n (%) |
32 (25.0%) |
Prevalent atrial fibrillation, n (%) |
24 (18.6%) |